Gara Jalqabaatti › Obesity › Arizona › Phoenix
Qorannoo klinikaalii Obesity Phoenix, AZ keessatti
Qorannoo 22 Obesity f Phoenix fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Namoota walitti qabaa jiraSadarkaa 3
- Synexus Clinical Research US, Inc., Phoenix
- Medical Advancement Centers of Arizona, Phoenix
Early Tracking of Childhood Health Determinants (ETCHED) Study
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- NIDDK, Phoenix, Phoenix
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Namoota walitti qabaa jiraSadarkaa 3
- RIO Clinical Trials - Phoenix, Phoenix
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Namoota walitti qabaa jiraSadarkaa 3
- Elite Clinical Studies, LLC, Phoenix
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Phoenix
Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
- NIDDK, Phoenix, Phoenix
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Namoota walitti qabaa jiraSadarkaa 3
- AURORA-2 Clinical Site, Phoenix
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Namoota walitti qabaa jiraSadarkaa 3
- HonorHealth, Phoenix
- Medical Advancement Centers of Arizona, Phoenix
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Namoota walitti qabaa jiraSadarkaa 3
- AURORA-1 Clinical Site, Phoenix
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Namoota walitti qabaa jiraSadarkaa 2
- Helios Clinical Research - Phoenix, Phoenix
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Namoota walitti qabaa jiraSadarkaa 3Hojjettoota fayyaa simatamoo
- ACCOMPLISH-2 Research Site, Phoenix
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
Namoota walitti qabaa jiraSadarkaa 2
- Synexus Clinical Research US, Inc., Phoenix
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Namoota walitti qabaa jiraSadarkaa 4
- Medical Dermatology Specialists, Phoenix
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Namoota walitti qabaa jiraSadarkaa 3
- Kailera Clinical Site, Phoenix
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
Namoota walitti qabaa jiraSadarkaa 3
- Kailera Clinical Site, Phoenix
The Effects of Increasing Caloric Intake on Diet-Induced Thermogenesis and 24h Energy Expenditure
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
- NIDDK, Phoenix, Phoenix
Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostics for Obesity
Namoota walitti qabaa jiraQorannoo ilaalaa
- Exponent Phoenix, Phoenix
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Namoota walitti qabaa jiraSadarkaa 3
- Honor Health, Phoenix
- Arizona Research Center, Phoenix
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Namoota walitti qabaa jiraSadarkaa 3
- ACCOMPLISH-1 Research Site, Phoenix
Fibrosis Lessens After Metabolic Surgery
Namoota walitti qabaa jiraSadarkaa 4Hojjettoota fayyaa simatamoo
- Banner Health Center, Phoenix
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Namoota walitti qabaa jiraSadarkaa 3
- Arizona Research Center, Inc., Phoenix
Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation
Namoota walitti qabaa jiraSadarkaa 3
- The University of Arizona College of Medicine- Phoenix, Phoenix
Qorannoo Obesity magaalota biroo keessatti
- Houston, TXQorannoo 43
- Chicago, ILQorannoo 41
- New York City, NYQorannoo 40
- San Antonio, TXQorannoo 40
- Washington, DCQorannoo 33
- Orlando, FLQorannoo 32
- Dallas, TXQorannoo 30
- Boston, MAQorannoo 28
- Las Vegas, NVQorannoo 27
- Miami, FLQorannoo 27
- Baltimore, MDQorannoo 26
- Jacksonville, FLQorannoo 25
Qorannoo biroo Phoenix keessatti
- Saree OljooQorannoo 25
- Kansarii ColorectalQorannoo 25
- Kansara MetastatikiiQorannoo 20
- Kansara Qara'a Non-Small CellQorannoo 20
- Cufama OnneeQorannoo 18
- Saree (Gosoota Hunda)Qorannoo 17
- Kansarii ProstateQorannoo 17
- Dhibee Onneessaa fi DhiigaQorannoo 16
- Myeloma Baay’eeQorannoo 16
- Kansarii PancreasQorannoo 16
- Baayyee UlfaataaQorannoo 15
- Dhukkubaa AlzheimerQorannoo 15
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.